Publications of Ruth M. Stassart
All genres
Journal Article (18)
1.
Journal Article
26, pp. 1218 - 1228 (2023)
Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease. Nature Neuroscience 2.
Journal Article
26, pp. 1145 - 1146 (2023)
Lack of myelin improves axon survival in inflammatory lesions in the CNS. Nature Neuroscience 3.
Journal Article
618, pp. 349 - 357 (2023)
Myelin dysfunction drives amyloid-β deposition in models of Alzheimer's disease. Nature 4.
Journal Article
146 (21), dev151704 (2019)
Axo-glial interdependence in peripheral nerve development. Development 5.
Journal Article
10, 1467 (2019)
NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies. Nature Communications 6.
Journal Article
9, 3025 (2018)
Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy. Nature Communications 7.
Journal Article
12, 467 (2018)
The Axon-myelin unit in development and degenerative disease. Frontiers in Neuroscience 8.
Journal Article
8, 14241 (2017)
Dietary cholesterol promotes repair of demyelinated lesions in the adult brain. Nature Communications 9.
Journal Article
2 (8), pp. 787 - 796 (2015)
Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease. Annals of Clinical and Translational Neurology 10.
Journal Article
269, pp. 90 - 92 (2015)
Nerve regeneration: specific metabolic demands? Experimental Neurology 11.
Journal Article
20 (9), pp. 1055 - 1061 (2014)
Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. Nature Medicine 12.
Journal Article
94 (4), pp. 533 - 546 (2014)
Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model. The American Journal of Human Genetics 13.
Journal Article
16 (1), pp. 48 - 54 (2013)
A role for Schwann cell-derived neuregulin-1 in remyelination. Nature Neuroscience 14.
Journal Article
102 (1), pp. 89 - 113 (2012)
Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease. British Medical Bulletin 15.
Journal Article
109 (10), pp. 3973 - 3978 (2012)
Lithium enhances remyelination of peripheral nerves. Proceedings of the National Academy of Sciences of the United States of America 16.
Journal Article
135 (1), pp. 72 - 87 (2012)
A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients. Brain 17.
Journal Article
42 (1), pp. 1 - 8 (2011)
The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration. Neurobiology of Disease 18.
Journal Article
59 (4), pp. 581 - 595 (2008)
Neuregulin-1/ErbB Signaling Serves Distinct Functions in Myelination of the Peripheral and Central Nervous System. Neuron Review Article (1)
19.
Review Article
146 (21), dev151704 (2019)
Axo-glial interdependance in peripheral nerve development. Development Preprint (1)
20.
Preprint
Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease. bioRxiv (2021)